- Home
- NERV vs USEA Comparison
NERV vs USEA Comparison
Compare NERV & USEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- USEA
- Stock Information
- Founded
- NERV 2007
- USEA 2004
- Country
- NERV United States
- USEA Greece
- Employees
- NERV N/A
- USEA N/A
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- USEA Marine Transportation
- Sector
- NERV Health Care
- USEA Consumer Discretionary
- Exchange
- NERV Nasdaq
- USEA Nasdaq
- Market Cap
- NERV 12.4M
- USEA 10.5M
- IPO Year
- NERV 2014
- USEA N/A
- Fundamental
- Price
- NERV $1.52
- USEA $1.30
- Analyst Decision
- NERV Hold
- USEA Strong Buy
- Analyst Count
- NERV 1
- USEA 1
- Target Price
- NERV $5.00
- USEA $6.00
- AVG Volume (30 Days)
- NERV 5.9K
- USEA 19.5K
- Earning Date
- NERV 05-13-2025
- USEA 05-27-2025
- Dividend Yield
- NERV N/A
- USEA 17.74%
- EPS Growth
- NERV N/A
- USEA N/A
- EPS
- NERV 0.82
- USEA N/A
- Revenue
- NERV N/A
- USEA $45,439,000.00
- Revenue This Year
- NERV N/A
- USEA N/A
- Revenue Next Year
- NERV N/A
- USEA $11.02
- P/E Ratio
- NERV $1.95
- USEA N/A
- Revenue Growth
- NERV N/A
- USEA 25.98
- 52 Week Low
- NERV $1.15
- USEA $1.00
- 52 Week High
- NERV $3.69
- USEA $2.90
- Technical
- Relative Strength Index (RSI)
- NERV 40.93
- USEA 58.77
- Support Level
- NERV $1.58
- USEA $1.30
- Resistance Level
- NERV $1.74
- USEA $1.40
- Average True Range (ATR)
- NERV 0.06
- USEA 0.04
- MACD
- NERV -0.01
- USEA 0.03
- Stochastic Oscillator
- NERV 0.00
- USEA 69.87
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About USEA United Maritime Corporation
United Maritime Corp operates as a shipping company currently specializing in the seaborne transportation of dry bulk commodities. It currently operates one LR2 tanker vessel and three Capesize dry bulk vessels, two Kamsarmax dry bulk vessels, and three Panamax dry bulk vessels, with an aggregate cargo-carrying capacity of approximately 1,004,289 dwt.